Enza + LA (n=355) | Placebo + LA (n=358) | Enza mono (n=355) | |
Prior RT (yes) | |||
n | 265 | 283 | 256 |
Events | 37 | 76 | 43 |
Median (95% CI). months | NR (NR–NR) | 85.1 (80.1–NR) | NR (NR–NR) |
HR (95% CI) | 0.45 (0.30–0.66) | – | 0.57 (0.39–0.82) |
Nominal p-value | <0.0001 | – | 0.0025 |
Prior RT (no) | |||
n | 90 | 75 | 99 |
Events | 8 | 16 | 20 |
Median (95% CI), months | NR (NR–NR) | NR (NR–NR) | NR (NR–NR) |
HR (95% CI) | 0.37 (0.16–0.87) | – | 0.93 (0.48–1.79) |
Nominal p-value | 0.0169 | – | 0.8259 |
Swetha Sridharan, MBBS
Calvary Mater Newcastle Hospital
Waratah, NSW